Micro-Tech Nanjing Co Ltd
SSE:688029
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
56.6
98.82
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Micro-Tech Nanjing Co Ltd
Accounts Receivables
Micro-Tech Nanjing Co Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Micro-Tech Nanjing Co Ltd
SSE:688029
|
Accounts Receivables
¥410m
|
CAGR 3-Years
26%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Accounts Receivables
¥6.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Accounts Receivables
¥1.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Accounts Receivables
¥768.6m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Accounts Receivables
¥620.5m
|
CAGR 3-Years
42%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Accounts Receivables
¥1.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
Micro-Tech Nanjing Co Ltd
Glance View
Micro-Tech (Nanjing) Co., Ltd. engages in the manufacture of medical equipment. The company is headquartered in Nanjing, Jiangsu and currently employs 2,315 full-time employees. The company went IPO on 2019-07-22. The firm's main products include three series of endoscopic diagnosis and treatment instruments used with endoscopes, microwave ablation equipment and consumables, and disposable endoscopes. Endoscopic diagnosis and treatment equipment mainly includes biopsy, hemostasis and closure, Endoscopic Mucosal Resection (EMR)/Endoscopic Submucosal Dissection (ESD), dilation, and Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Ultrasonography (EUS) and Endobronchial Ultrasound (EBUS) products. Microwave ablation mainly includes microwave ablation instrument and microwave ablation needle series products. Disposable endoscope mainly includes disposable biliopancreatic imaging system (choledochoscope) and related consumables and other products.
See Also
What is Micro-Tech Nanjing Co Ltd's Accounts Receivables?
Accounts Receivables
410m
CNY
Based on the financial report for Dec 31, 2023, Micro-Tech Nanjing Co Ltd's Accounts Receivables amounts to 410m CNY.
What is Micro-Tech Nanjing Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
25%
Over the last year, the Accounts Receivables growth was 45%. The average annual Accounts Receivables growth rates for Micro-Tech Nanjing Co Ltd have been 26% over the past three years , 25% over the past five years .
You don't have any saved screeners yet
